John Nkengasong | |
---|---|
United States Global AIDS Coordinator United States Special Representative for Global Health Diplomacy | |
Assumed office June 13, 2022 | |
President | Joe Biden |
Preceded by | Deborah Birx |
1st Director of the Africa Centres for Disease Control and Prevention [1] | |
In office 2016 –May 2022 | |
Preceded by | Post established |
Succeeded by | Jean Kaseya |
Personal details | |
Born | Douala,Cameroon |
Education | University of YaoundéI (BS) Institute of Tropical Medicine Antwerp (MS) Vrije Universiteit Brussel (MSc) Vrije Universiteit Brussel (PhD) |
John N. Nkengasong is a Cameroonian-American virologist serving as the Global AIDS Coordinator in the Biden administration since 2022 and Senior Bureau Official for Global Health Security and Diplomacy since 2023. He previously worked as the Director of the Africa Centres for Disease Control and Prevention from 2016 to 2022,as well as at the World Health Organization (WHO) and Centers for Disease Control and Prevention. During the COVID-19 pandemic,Nkengasong was appointed the WHO Special Envoy for Africa.
Nkengasong is from Cameroon. [2] He became interested in biology,chemistry and mathematics whilst he was at high school. [3]
Nkengasong earned his undergraduate degree at the University of YaoundéI. [3] During his undergraduate degree he met Peter Piot,who encouraged him to visit Antwerp as a graduate student in virology. He ended up studying biomedical sciences at the Institute of Tropical Medicine Antwerp. [4] After completing his second degree,he moved to the Vrije Universiteit Brussel,where he earned a master's degree in medical sciences. [4] After earning his master's degree,Nkengasong then joined the research group of Guido van der Groen and Piot, [2] eventually earning a doctorate degree in medical sciences (virology) from Vrije Universiteit Brusse. [5] His doctoral research was the first to characterize all of the genetic subtypes of HIV in Africa. [3] He later completed a management qualification at the John F. Kennedy School of Government. [6]
In 1993,Nkengasong joined the World Health Organization,where he served as Chief of Virology. [7] He was based in the Collaborating Centre for HIV/AIDS Diagnostics in the Institute of Tropical Medicine Antwerp. [2] He has worked on the diagnosis,pathogenesis and drug resistance of HIV/AIDS. [8]
After a couple of years,Nkengasong moved to the United States Centers for Disease Control and Prevention where he worked as Chief of Virology in Abidjan. [2] In preparation for this job he was trained in Berkeley as part of the John E. Fogarty International Center. [9] Nkengasong worked alongside Mike Hendry,who was running the HIV diagnosis program at the California State Laboratory. [9]
In 2011,Nkengasong helped to establish the African Society for Laboratory Medicine (ASLM). [10] The ASLM looks to support African researchers in developing their laboratory medicine capabilities and ability to care for patients. [11]
In 2016,Nkengasong joined the Africa Centres for Disease Control and Prevention as its inaugural Director. [12] [13] At the Africa CDC,Nkengasong oversees the Regional Integrated Surveillance and Laboratory Networks (RISLNET) with a focus on empowering local leadership. [11] [14] [15]
During the COVID-19 pandemic,Nkengasong was appointed a special envoy to the director general of the World Health Organization. [16] In this capacity,he was responsible for amplifying the messages of the Director General as well as providing strategic advice on preparedness. [16] [17] Nkengasong led Africa's response to coronavirus disease,including training a team of young responders;the African Healthcare Volunteer Workforce. [18] [19] Protecting the African population from coronavirus disease is complicated by challenges such as difficulties in testing in regions affected by conflicts and issues with social distancing in urban slums. [20]
In the preparations for the Global Health Summit hosted by the European Commission and the G20 in May 2021,Nkengasong co-chaired the event's High-Level Scientific Panel. [21]
On September 27,2021,President Joe Biden nominated Nkengasong to be the Ambassador-at-Large for Global Health Diplomacy and Global AIDS Coordinator in the Department of State. Nkengasong's initial nomination expired at the end of the year and was returned to President Biden on January 3,2022. [22]
President Biden resent his nomination the following day. The Senate Foreign Relations Committee held hearings on Nkengasong's nomination on March 15,2022. The committee favorably reported his nomination on May 4,2022. On May 5,2022,the United States Senate confirmed his nomination by voice vote. [23] [24] He was sworn in on June 13,2022. [25]
On August 1,2023,Secretary of State Antony Blinken chose Nkengasong to lead the newly formed Bureau of Global Health Security and Diplomacy (GHSD),focused on coordinating international responses to infectious diseases. [25]
The Joint United Nations Programme on HIV and AIDS is the main advocate for accelerated, comprehensive and coordinated global action on the HIV/AIDS pandemic.
World AIDS Day, designated on 1 December every year since 1988, is an international day dedicated to raising awareness of the AIDS pandemic caused by the spread of HIV infection and mourning those who've died of the disease. The acquired immunodeficiency syndrome (AIDS) is a life-threatening condition caused by the human immunodeficiency virus (HIV). The HIV virus attacks the immune system of the patient and reduces its resistance to other diseases. Government and health officials, non-governmental organizations, and individuals around the world observe the day, often with education on AIDS prevention and control.
Sir Peter Karel, Baron Piot, is a Belgian-British microbiologist known for his research into Ebola and AIDS.
The United States President's Emergency Plan For AIDS Relief (PEPFAR) is a United States governmental initiative to address the global HIV/AIDS epidemic and help save the lives of those suffering from the disease. Launched by U.S. President George W. Bush in 2003, as of May 2020, PEPFAR has provided about $90 billion in cumulative funding for HIV/AIDS treatment, prevention, and research since its inception, making it the largest global health program focused on a single disease in history until the COVID-19 pandemic. PEPFAR is implemented by a combination of U.S. government agencies in over 50 countries and overseen by the Global AIDS Coordinator at the United States Department of State. As of 2023, PEPFAR has saved over 25 million lives, primarily in sub-Saharan Africa.
Male circumcision reduces the risk of human immunodeficiency virus (HIV) transmission from HIV positive women to men in high risk populations.
The global epidemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), by 2023, HIV/AIDS had killed approximately 40.4 million people, and approximately 39 million people were infected with HIV globally. Of these, 29.8 million people (75%) are receiving antiretroviral treatment. There were about 630,000 deaths from HIV/AIDS in 2022. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2020, there are approximately 1.5 million new infections of HIV per year globally.
Infection with HIV, a retrovirus, can be managed with treatment but without treatment can lead to a spectrum of conditions including AIDS.
Seth Franklin Berkley is an American medical epidemiologist and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI) and former CEO of Gavi, the Vaccine Alliance. He is currently a senior advisor to the Pandemic Center at Brown University School of Public Health.
Robert Ray Redfield Jr. is an American virologist who served as the Director of the U.S. Centers for Disease Control and Prevention and the Administrator of the Agency for Toxic Substances and Disease Registry from 2018 to 2021.
Discrimination against people with HIV/AIDS or serophobia is the prejudice, fear, rejection, and stigmatization of people with HIV/AIDS. Marginalized, at-risk groups such as members of the LGBTQ+ community, intravenous drug users, and sex workers are most vulnerable to facing HIV/AIDS discrimination. The consequences of societal stigma against PLHIV are quite severe, as HIV/AIDS discrimination actively hinders access to HIV/AIDS screening and care around the world. Moreover, these negative stigmas become used against members of the LGBTQ+ community in the form of stereotypes held by physicians.
Quarraisha Abdool Karim is an infectious diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New York and Pro-Vice Chancellor for African Health, University of KwaZulu-Natal, South Africa.
Salim S. Abdool Karim, MBChB, MMed, MS(Epi), FFPHM, FFPath (Virol), DipData, PhD, DSc(hc), FRS is a South African public health physician, epidemiologist and virologist who has played a leading role in the AIDS and COVID-19 pandemic. His scientific contributions have impacted the landscape of HIV prevention and treatment, saving thousands of lives.
Matshidiso Rebecca Natalie Moeti is a physician, public health specialist and medical administrator from Botswana who has been serving as Regional Director of the World Health Organization Regional Office for Africa (AFRO), headquartered in Brazzaville, the Republic of the Congo, since 2015.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Deborah Leah Birx is an American physician and diplomat who served as the White House Coronavirus Response Coordinator under President Donald Trump from 2020 to 2021. Birx specializes in HIV/AIDS immunology, vaccine research, and global health. Starting in 2014, she oversaw the implementation of the President's Emergency Plan for AIDS Relief (PEPFAR) program to support HIV/AIDS treatment and prevention programs in 65 countries. From 2014-2020, Birx was the United States global AIDS coordinator for presidents Barack Obama and Donald Trump and served as the United States special representative for global health diplomacy between 2015 and 2021. Birx was part of the White House Coronavirus Task Force from February 2020 to January 2021. In March 2021, Birx joined ActivePure Technology as Chief Medical and Science Advisor.
Linda-Gail Bekker MBChB, DTMH, DCH, FCP(SA) is a Professor of Medicine and Chief Operating Officer of the Desmond Tutu HIV Foundation. She is also Director of the Desmund Tutu HIV Centre at the University of Cape Town. She is a Past President of the International AIDS Society (2016-18).
Alash'le Grace Abimiku is a Nigerian executive director of the International Research Centre of Excellence at the Institute of Human Virology Nigeria and a professor of virology at the University of Maryland School of Medicine who takes interest in the prevention and treatment of HIV.
The Africa Centres for Disease Control and Prevention is a public health agency of the African Union to support the public health initiatives of member states and strengthen the capacity of their health institutions to deal with disease threats. The Africa CDC ideas was proposed by the government of Ethiopia in 2013 during a TB/HIV special summit in Abuja, Nigeria. From 2013 to 2016, the modalities and statue of Africa CDC were developed and the specialized agency was officially launched in January 2017.
Ahmed E. Ogwell Ouma is a Kenyan public health specialist and an expert in health policy, health security, global health diplomacy and non-communicable diseases. He is currently the acting Director of the Africa Centres for Disease Control and Prevention.